Recruiting studies: Lipodystrophy Partial

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Metabolic Phenotyping in vEDS
Phase N/A · 1 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT07516496 Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Phase 4 · 12 location(s) · Amryt Pharma · NCT06484868 Low Energy Diet and Familial Partial Lipodystrophy
NA · 1 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT03900286 Registry for Patients With Lipodystrophy
Phase N/A · 28 location(s) · University of Ulm · NCT03553420 Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Phase 3 · 7 location(s) · Chiesi Farmaceutici S.p.A. · NCT06679270 MEASuRE: Metreleptin Effectiveness And Safety Registry
Phase N/A · 28 location(s) · Chiesi Farmaceutici S.p.A. · NCT02325674 Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
Phase 3 · 3 location(s) · Regeneron Pharmaceuticals · NCT07220785 Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
Phase 2 · 1 location(s) · University of Michigan · NCT07091734 Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunni
NA · 1 location(s) · Centre Hospitalier Universitaire de la Réunion · NCT05789251 Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05996536 Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
Phase 2 · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05470504

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.